Transce3nd LLC Buys Shares of 150 Humana Inc. (NYSE:HUM)

Transce3nd LLC purchased a new position in shares of Humana Inc. (NYSE:HUM) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 150 shares of the insurance provider’s stock, valued at approximately $38,000.

Other institutional investors have also modified their holdings of the company. FPC Investment Advisory Inc. purchased a new stake in Humana during the fourth quarter worth about $27,000. Centricity Wealth Management LLC purchased a new stake in Humana during the 4th quarter worth approximately $30,000. LFA Lugano Financial Advisors SA increased its stake in Humana by 56.3% during the 4th quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider’s stock worth $32,000 after buying an additional 45 shares during the period. OFI Invest Asset Management acquired a new stake in Humana during the 4th quarter worth approximately $33,000. Finally, Atwood & Palmer Inc. boosted its position in Humana by 64.5% in the 4th quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider’s stock valued at $39,000 after buying an additional 60 shares during the period. 92.38% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the company. Piper Sandler lifted their target price on Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a report on Wednesday, January 15th. StockNews.com upgraded shares of Humana from a “hold” rating to a “buy” rating in a research note on Monday, April 7th. Mizuho lifted their price target on shares of Humana from $305.00 to $316.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 9th. JPMorgan Chase & Co. dropped their price objective on shares of Humana from $257.00 to $256.00 and set a “neutral” rating on the stock in a research report on Tuesday, February 18th. Finally, Morgan Stanley decreased their price objective on shares of Humana from $301.00 to $285.00 and set an “equal weight” rating for the company in a research report on Wednesday, February 12th. Seventeen investment analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $284.90.

Humana Stock Up 5.3 %

HUM stock opened at $258.87 on Wednesday. The stock has a market capitalization of $31.24 billion, a PE ratio of 26.02, a price-to-earnings-growth ratio of 2.05 and a beta of 0.62. The company has a fifty day moving average of $265.74 and a 200-day moving average of $270.19. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76. Humana Inc. has a one year low of $213.31 and a one year high of $406.46.

Humana (NYSE:HUM) last announced its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, beating analysts’ consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. As a group, analysts expect that Humana Inc. will post 16.47 EPS for the current year.

Humana Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be given a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.37%. The ex-dividend date of this dividend is Friday, June 27th. Humana’s payout ratio is 35.58%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.